公司资料
UnitedHealth Group 股价、新闻与催化剂
- 股票代码:
- UNH
- 交易所:
- NYSE
- 行业:
- Healthcare Services
- 所在地:
- United States
股票表现
365.20 USD (-0.51%)
收盘价
最后更新: 2026年10月1日
343B USD
市值
股价为何变动
截至 2026年10月1日，UNH 下跌 0.51%，收于 $365.20。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
UnitedHealth Group is a diversified healthcare company with insurance, care delivery, and services operations through UnitedHealthcare and Optum. The company’s story is driven more by managed-care scale, services growth, and operating execution than by classic biotech catalysts.
所在地与行业分类
Headquartered in the United States and listed on NYSE, UnitedHealth sits in managed care and healthcare services. Its geographic footprint is broad and largely U.S.-centered, with a large national commercial presence.
商业模式特征
The business combines premium revenue, healthcare services, data-enabled operations, and care delivery infrastructure. Investors tend to watch membership trends, medical cost ratios, Optum growth, and regulatory or reimbursement pressure.
生物医药行业定位
UnitedHealth is not a biotech company, but it matters to healthcare investors because it sits at the center of payer and provider economics. Its stock is driven by operational and policy factors rather than drug-development catalysts.
未来催化剂
- UnitedHealth Group's catalyst setup now looks most tied to CRB-701, CANYON-1, and the rest of its current pipeline. What gives this more shape is “Having reached broad alignment with the FDA, we’re on track to start a registrational study for CRB-701 in second-line HNSCC this summer. That setup makes the next update more important than the headline financials themselves.
近期新闻
新闻标题由机器翻译，详情为英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。